Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,786,064
+$345,079 QoQ
Shares Held
18,845
+3.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.96%
of 13F equity value
Holder Rank
#1,652
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Shoker Investment Counsel, Inc. holds $20,628,640 across 8 Drug Manufacturers - General names. JNJ ranks #2 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
21,930 | $5,518,465 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
18,845 | $4,786,064 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,948 | $3,848,318 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
20,774 | $2,624,587 | |
| 5 | PFE |
Pfizer Inc
|
99,923 | $2,406,145 | |
| 6 | LLY |
ELI LILLY & Co
|
668 | $801,219 | |
| 7 | NVS |
Novartis AG
|
2,335 | $365,941 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,823 | $277,901 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,786,064 | 18,845 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,440,985 | 18,168 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,955,849 | 19,115 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $3,604,008 | 19,437 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,964,113 | 19,405 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,175,338 | 19,147 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,685,738 | 18,571 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,972,990 | 18,345 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,754,531 | 18,846 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,946,288 | 18,625 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $2,899,376 | 18,498 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,862,373 | 18,378 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,070,561 | 18,551 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,855,565 | 18,423 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,242,764 | 18,357 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,013,992 | 18,450 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,181,689 | 17,924 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,113,576 | 17,568 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,157,610 | 18,458 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,009,068 | 18,632 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $3,114,574 | 18,906 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $3,075,481 | 18,713 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,984,711 | 18,965 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,827,231 | 18,990 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,732,300 | 19,429 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,534,480 | 19,328 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||